Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TCTEX1D2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
mRNA | PPP1R13B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | PRLHR | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
mRNA | NOTO | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
mRNA | NRXN1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
mRNA | TBX18 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
mRNA | TRIM36 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
mRNA | ZNF736 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | SLK | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
mRNA | LSM10 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |